The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BLACK STONE MINERALS | BSM | 09225M101 | 49,877,737 | 5,719,924 | SH | SOLE | 0 | 0 | 0 | ||
| UNITY BIOTECHNOLOGY INC | UBX | 91381U101 | 9,431,886 | 1,571,981 | SH | SOLE | 0 | 0 | 0 | ||
| EVELO BIOSCIENCES INC | EVLO | 299734103 | 5,127,889 | 479,242 | SH | SOLE | 0 | 0 | 0 | ||
| BIOSIG TECH INC | BSGM | 09073N201 | 434,840 | 100,891 | SH | SOLE | 0 | 0 | 0 | ||
| Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC) | CLPT | 18507C103 | 846,446 | 40,040 | SH | SOLE | 0 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc | ZNTL | 98943L107 | 15,727,096 | 362,459 | SH | SOLE | 0 | 0 | 0 | ||
| Sorrento Therapeutics | SRNE | 83587F202 | 5,291,493 | 639,842 | SH | SOLE | 0 | 0 | 0 | ||
| Teladoc Health Inc Com | TDOC | 87918A105 | 119,773 | 659 | SH | SOLE | 0 | 0 | 0 | ||